Clinical Case Discussion

Intermediate-risk Prostate Cancer: The Case for Active Surveillance

Marc Dall'Era, Benjamin J. Davies

Research output: Contribution to journalComment/debate

Abstract

Active surveillance offers men the opportunity to defer immediate local treatment of low risk prostate cancer while preserving a highly functional quality of life. Novel biomarkers and imaging technology will enable physicians to better identify ideal candidates for this approach beyond traditional clinical characteristics.

Original languageEnglish (US)
Pages (from-to)208-209
Number of pages2
JournalEuropean Urology Focus
Volume1
Issue number2
DOIs
StatePublished - Sep 1 2015

Fingerprint

Prostatic Neoplasms
Biomarkers
Quality of Life
Technology
Physicians
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Clinical Case Discussion : Intermediate-risk Prostate Cancer: The Case for Active Surveillance. / Dall'Era, Marc; Davies, Benjamin J.

In: European Urology Focus, Vol. 1, No. 2, 01.09.2015, p. 208-209.

Research output: Contribution to journalComment/debate

@article{f4f4dc7f7e26437bb2c7fe58d63c1b70,
title = "Clinical Case Discussion: Intermediate-risk Prostate Cancer: The Case for Active Surveillance",
abstract = "Active surveillance offers men the opportunity to defer immediate local treatment of low risk prostate cancer while preserving a highly functional quality of life. Novel biomarkers and imaging technology will enable physicians to better identify ideal candidates for this approach beyond traditional clinical characteristics.",
author = "Marc Dall'Era and Davies, {Benjamin J.}",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.euf.2015.07.001",
language = "English (US)",
volume = "1",
pages = "208--209",
journal = "European Urology Focus",
issn = "2405-4569",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Clinical Case Discussion

T2 - Intermediate-risk Prostate Cancer: The Case for Active Surveillance

AU - Dall'Era, Marc

AU - Davies, Benjamin J.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Active surveillance offers men the opportunity to defer immediate local treatment of low risk prostate cancer while preserving a highly functional quality of life. Novel biomarkers and imaging technology will enable physicians to better identify ideal candidates for this approach beyond traditional clinical characteristics.

AB - Active surveillance offers men the opportunity to defer immediate local treatment of low risk prostate cancer while preserving a highly functional quality of life. Novel biomarkers and imaging technology will enable physicians to better identify ideal candidates for this approach beyond traditional clinical characteristics.

UR - http://www.scopus.com/inward/record.url?scp=84960414421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960414421&partnerID=8YFLogxK

U2 - 10.1016/j.euf.2015.07.001

DO - 10.1016/j.euf.2015.07.001

M3 - Comment/debate

VL - 1

SP - 208

EP - 209

JO - European Urology Focus

JF - European Urology Focus

SN - 2405-4569

IS - 2

ER -